-
1
-
-
79953714529
-
-
Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT; October
-
Boehringer Ingelheim Pharmaceuticals, Inc. Pradaxa (dabigatran etexilate) package insert. Ridgefield, CT; October 2010.
-
(2010)
Pradaxa (Dabigatran Etexilate) Package Insert
-
-
-
2
-
-
0002531456
-
Studies on the hemorrhagic sweet clover disease. I. The preparation of hemorrhagic concentrates
-
Campbell HA, Roberts WL, Smith WK, Link KP. Studies on the hemorrhagic sweet clover disease. I. The preparation of hemorrhagic concentrates. J Biol Chem 1940;136:47-55.
-
(1940)
J Biol Chem
, vol.136
, pp. 47-55
-
-
Campbell, H.A.1
Roberts, W.L.2
Smith, W.K.3
Link, K.P.4
-
3
-
-
0000593527
-
Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent
-
Stahmann MA, Huebner CF, Link KP. Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent. J Biol Chem 1941;138:513-27.
-
(1941)
J Biol Chem
, vol.138
, pp. 513-527
-
-
Stahmann, M.A.1
Huebner, C.F.2
Link, K.P.3
-
4
-
-
34347394385
-
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
-
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stoke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67. (Pubitemid 351650486)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.12
, pp. 857-867
-
-
Hart, R.G.1
Pearce, L.A.2
Aguilar, M.I.3
-
5
-
-
33646081030
-
The PROTECT-AF Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation trial
-
Fountain RB, Holmes DR, Chandrasekaran K, et al. The PROTECT-AF Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation trial. Am Heart J 2006;151:956-61.
-
(2006)
Am Heart J
, vol.151
, pp. 956-961
-
-
Fountain, R.B.1
Holmes, D.R.2
Chandrasekaran, K.3
-
6
-
-
20444482131
-
Safety of ximelagatran
-
letter
-
Brinker A, HE R, Desai M, Gelperin K, Robie-Suh K. Safety of ximelagatran [letter]. JAMA 2005;293(23):2859.
-
(2005)
JAMA
, vol.293
, Issue.23
, pp. 2859
-
-
Brinker, A.1
He, R.2
Desai, M.3
Gelperin, K.4
Robie-Suh, K.5
-
7
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults
-
Go A, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285(18):2370-5.
-
(2001)
JAMA
, vol.285
, Issue.18
, pp. 2370-2375
-
-
Go, A.1
Hylek, E.M.2
Phillips, K.A.3
-
8
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusef S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusef, S.3
-
9
-
-
35348879239
-
Dabigatran with or Without Concomitant Aspirin Compared with Warfarin Alone in Patients with Nonvalvular Atrial Fibrillation (PETRO Study)
-
DOI 10.1016/j.amjcard.2007.06.034, PII S0002914907014610
-
Ezekowitz MD, Reilly PA, Nehmiz G, et al. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation: PETRO study. Am J Cardiol 2007;100(9):1419-26. (Pubitemid 47576022)
-
(2007)
American Journal of Cardiology
, vol.100
, Issue.9
, pp. 1419-1426
-
-
Ezekowitz, M.D.1
Reilly, P.A.2
Nehmiz, G.3
Simmers, T.A.4
Nagarakanti, R.5
Parcham-Azad, K.6
Pedersen, K.E.7
Lionetti, D.A.8
Stangier, J.9
Wallentin, L.10
-
10
-
-
78049490509
-
Newly identified events in the RE-LY trial
-
letter
-
Connolly SJ, Ezekowitz MD, Yusuf S, Reilly PA, Wallentin L. Newly identified events in the RE-LY trial [letter]. N Engl J Med 2010;363:1875-6.
-
(2010)
N Engl J Med
, vol.363
, pp. 1875-1876
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Reilly, P.A.4
Wallentin, L.5
-
11
-
-
79551589662
-
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation
-
Freeman JV, Zhu RP, Owens DK, et al. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med 2011;154:1-11.
-
(2011)
Ann Intern Med
, vol.154
, pp. 1-11
-
-
Freeman, J.V.1
Zhu, R.P.2
Owens, D.K.3
-
12
-
-
79953694149
-
-
Drugstore.com. Available from Accessed January 25, 2011
-
Drugstore.com. Pradaxa. Available from http://www.drugstore.com/pradaxa/ bottle-60-150mg-capsules/qxn00597013554. Accessed January 25, 2011.
-
Pradaxa
-
-
-
13
-
-
79952489817
-
Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation
-
published online ahead of print November 26, Available from
-
Lam YY, Ma TKW, Yan BP. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation [published online ahead of print November 26, 2010]. Int J Cardiol. Available from http://dx.doi.org/10.1016/j.ijcard.2010.10.017.
-
(2010)
Int J Cardiol
-
-
Lam, Y.Y.1
Tkw, M.2
Yan, B.P.3
|